The Role

An exciting opportunity exists for a Senior Project Manager, to lead the management of Biomedical Translation Bridge (BTB) Program for UniQuest.

  • Work with an industry leader as a key part of a national biomedical translation initiative based in Brisbane, Queensland;
  • Apply your project management skills to develop new therapeutics;
  • Drive academic interactions through oversight to delivery of specific project milestones
  • Competitive package

The opportunity

UniQuest is seeking an experienced Project Manager who will provide leadership in the recently launched  MRFF national initiative, Biomedical Translation Bridge (BTB) program.  In addition, they will provide input into the development of UniQuest’s drug discovery portfolio developed by its drug discovery initiative, QEDDI, including projects sourced from researchers at The University of Queensland. 

Success in this role will be achieved through the incumbent’s international drug discovery and development experience, scientific expertise, excellent academic and CRO interactions. This will enable the development and management of a drug development project plan.

The Senior Project Manager will have industry experience in managing therapeutic discovery and development activities, including responsibility for key relationship management and initiation, planning, execution, monitoring and completion of projects. The incumbent shall have experience in the discovery and development of small molecules and/or potential other modalities such as biologics preferably across a range of disease areas.

The role and responsibilities

The Senior Project Manager will work closely with Queensland Emory Drug Discovery Initiative (QEDDI), a new dedicated small molecule drug discovery and development capability. This role will also work closely with the Commercialisation teams of UniQuest together with the other BTB Partners, to lead the development of the BTB portfolio from initial academic interaction through oversight or delivery of specific project milestones. It is expected that the role will provide input in to the QEDDI portfolio of small molecule drug discovery and development projects. 

The Senior Project Manager is responsible for the initiation, planning, execution, monitoring and completion of therapeutic discovery and development at the project level and for the development of effective relationship with researchers, their institutions, commercialisation staff and Contract Research Organisations (CRO).

The key responsibilities will include:

  • Review and support the development of therapeutic projects from SMEs and academic groups applying to the MRFF BTB scheme that aim to ultimately result in preventative interventions, cures and treatments for important diseases;
  • Contribute to the mentoring of researchers to improve Australia’s capability in translation and the early commercialisation process;
  • Build highly effective relationships with researchers, key university staff, industry and others in the broader sector;
  • To support the delivery or agreed activities and milestones with project teams, consultants and CROs in accordance with agreed budgets and timeframes.

To be successful in your application, you will need to demonstrate the following essential knowledge and experience:

  • At least 5 to 10 years hands-on experience in the drug discovery and development industry, in a mixture of global big pharma, biotech and/or start-up environments, particularly in the non-clinical phase 
  • Proven track record of delivery of key milestones from preclinical target validation to preclinical/clinical studies
  • Strong working knowledge of all aspects of drug discovery pharmacology, DMPK, toxicology and regulatory requirements
  • Proven ability to contribute at a technical level to multiple programs simultaneously
  • Demonstrated experience in planning, development of customised plans and decision analysis in the area of drug discovery
  • Demonstrated experience in developing, managing and controlling cross functional project budgets, timelines and scope documents

The ideal candidate will have advanced interpersonal and communication skills, personal initiative, international pre-clinical drug development experience and scientific expertise in a relevant discipline. The successful candidate will also have proven project management skills, relevant industry experience (i.e. therapeutic development) and be able to work effectively as part of a team where collaboration is highly valued

Closing Date

Monday 19 August 2019, 5:00pm AEST.

Applicants must address the requirements as specified above and in the Position Description and include a current CV and covering letter (one page maximum) in the one document.

If you are interested in applying please send a current CV and a covering letter to

A similar opportunity is available at our venture partner BioCurate based in Melbourne, Australia and can be viewed here

A detailed outline of the Position Description is available below.

The Company

UniQuest is Australia’s top university-based commercialisation office, managing the intellectual property of The University of Queensland.  Since 1984, it has created more than 100 startups based on UQ research and raised more than $700 million.  UniQuest benchmarks in the top five per cent globally for university commercialisation, generating more licence income than the other Group of Eight universities. UniQuest manages an extensive intellectual property portfolio, including the HPV vaccine Gardasil.  Gross sales of products licensed by UniQuest have surpassed $US16 billion. More than $465 million in revenue has been returned to UQ. The Queensland Emory Drug Discovery Initiative (QEDDI), a division of UniQuest, is a drug discovery and development facility translating The University of Queensland’s biomedical research into new medicines to deliver faster health benefits.  QEDDI’s scientists are advancing medical research into new candidate therapies, enabling commercial partnerships and helping to bring more medicines to market.

About the Biomedical Translation Bridge (BTB) Program

The Biomedical Translation Bridge (BTB) Program is an initiative of the Medical Research Future Fund (MRFF), providing up to $1 million in matching funding to nurture the translation of new therapies, technologies and medical devices through to the proof of concept stage.

The BTB program is operated by MTPConnect in partnership with BioCurate (a joint venture of the Universities of Melbourne and Monash), UniQuest, the Medical Device Partnering Program (MDPP, led by Flinders University), and the Bridge and BridgeTech programs (Queensland University of Technology); all pre-eminent organisations engaged in the translation and commercialisation of health and medical research.

UniQuest and BioCurate will work closely together as Venture Partners with specific responsibility for drug therapeutic projects. This collaborative, national approach will bring unique value to BTB projects by leveraging the complementary expertise and decades of international industry experience that each group can provide.